Skip to contentN
National Health Investors Inc
N
NHINational Health Investors Inc Q4 2019 · 10-K
Revenue$82.20M$82.20M+11.1% vs Q4 2018 Net Income$42.04M$42.04M+13.4% vs Q4 2018 EPS Diluted$0.95$0.95+9.2% vs Q4 2018 Operating Cash Flowderived$56,146,000+8.2% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR
Margins · derivedNet margin51.1%+1.0 pt vs Q4 2018
ended Dec 31, 2019 · filed Feb 19, 2020 · 50 d after period end